Repeat CRS/HIPEC: It Comes Down to Tumor Biology and Ability to Achieve a Complete CRS

Ann Surg Oncol. 2022 Jun;29(6):3366-3368. doi: 10.1245/s10434-022-11429-z. Epub 2022 Feb 18.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Biology
  • Chemotherapy, Cancer, Regional Perfusion
  • Combined Modality Therapy
  • Cytoreduction Surgical Procedures
  • Humans
  • Hyperthermia, Induced*
  • Hyperthermic Intraperitoneal Chemotherapy
  • Neoplasms* / therapy
  • Retrospective Studies
  • Survival Rate